Technologies for analyzing proteome, metabolome, transcriptome, and epigenome data at both spatial and single-cell levels have come a long way. Taken together, these methods provide a holistic view of ...

"Transforming Biological Research and Personalized Medicine: Single-Cell Genomics and Proteomics Show Cellular Heterogeneity, Driving Advances in Disease Mechanisms, Drug Discovery, and Precision ...

Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics, played a key role ...

Proteomics and genomics share the common goal of characterizing biological systems, yet they differ fundamentally in their molecular targets, analytical challenges and interpretive value. Genomics ...

A number of companies are using the lessons and technologies of traditional genomics--the microarray chief among them--to delve into the more challenging world of functional genomics and proteomics.

New next generation sequencing-based proteomics kits designed to integrate with multiple NGS platforms, eliminating the need for new instrumentation or specialized expertise Thermo Fisher Scientific, ...

Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide. The severity of disease varies widely from mild illness to cirrhosis and hepatocellular carcinoma. The progression of liver ...

This featured session will highlight how multi-omic approaches powered by Seer’s Proteograph Product Suite are transforming translational genomics and clinical research. Brendan Keating, PhD, ...

Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The advent of ...

REDWOOD CITY, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the ...